Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bengt Winblad

Showing results (1-10 of 572) with videos related to

Pageof 58
Sort By:
CNS Drug Reviews|July 12, 2005
Piracetam: a review of pharmacological properties and clinical usesBengt Winblad
American Journal of Alzheimer'S Disease and Other Dementias|February 28, 2009
Donepezil in severe Alzheimer's diseaseBengt Winblad
Journal of the American Medical Directors Association|July 15, 2015
Brain health: a primary health care viewpointAnders Wimo, Bengt Winblad
Acta Neurologica Scandinavica. Supplementum|February 27, 2003
Treatment of mild cognitive impairment: rationale, present and future strategiesVesna Jelic, Bengt Winblad
Acta Neurologica Scandinavica. Supplementum|February 27, 2003
Pharmacoeconomics of mild cognitive impairmentAnders Wimo, Bengt Winblad
Alzheimer Disease and Associated Disorders|July 14, 2004
Long-term treatment of Alzheimer disease: efficacy and safety of acetylcholinesterase inhibitorsBengt Winblad, Vesna Jelic
Dementia and Geriatric Cognitive Disorders|January 24, 2004
Patients with Alzheimer's disease may be particularly susceptible to adverse effects of statinsAnnica Algotsson, Bengt Winblad
Handbook of Clinical Neurology|July 18, 2008
Economical aspects of dementiaAnders Wimo, Bengt Winblad
The Lancet. Neurology|July 10, 2003
Memantine offers new possibilities for the treatment of VaDBengt Winblad, Miia Kivipelto
Expert Review of Neurotherapeutics|November 14, 2007
A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementiaJeffrey Cummings, Bengt Winblad
Pageof 58

Showing results (1-10 of 572) with videos related to

Sort By:
Pageof 58
CNS Drug Reviews|July 12, 2005
Piracetam: a review of pharmacological properties and clinical usesBengt Winblad
American Journal of Alzheimer'S Disease and Other Dementias|February 28, 2009
Donepezil in severe Alzheimer's diseaseBengt Winblad
Journal of the American Medical Directors Association|July 15, 2015
Brain health: a primary health care viewpointAnders Wimo, Bengt Winblad
Acta Neurologica Scandinavica. Supplementum|February 27, 2003
Treatment of mild cognitive impairment: rationale, present and future strategiesVesna Jelic, Bengt Winblad
Acta Neurologica Scandinavica. Supplementum|February 27, 2003
Pharmacoeconomics of mild cognitive impairmentAnders Wimo, Bengt Winblad
Alzheimer Disease and Associated Disorders|July 14, 2004
Long-term treatment of Alzheimer disease: efficacy and safety of acetylcholinesterase inhibitorsBengt Winblad, Vesna Jelic
Dementia and Geriatric Cognitive Disorders|January 24, 2004
Patients with Alzheimer's disease may be particularly susceptible to adverse effects of statinsAnnica Algotsson, Bengt Winblad
Handbook of Clinical Neurology|July 18, 2008
Economical aspects of dementiaAnders Wimo, Bengt Winblad
The Lancet. Neurology|July 10, 2003
Memantine offers new possibilities for the treatment of VaDBengt Winblad, Miia Kivipelto
Expert Review of Neurotherapeutics|November 14, 2007
A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementiaJeffrey Cummings, Bengt Winblad
Pageof 58